PDT Partners’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Buy |
+27,280
| New | +$188K | 0.01% | 642 |
|
|
2024
Q2 | – | Sell |
-49,518
| Closed | -$467K | – | 695 |
|
|
2024
Q1 | $467K | Buy |
+49,518
| New | +$467K | 0.04% | 469 |
|
|
2023
Q2 | – | Sell |
-28,603
| Closed | -$81.5K | – | 604 |
|
|
2023
Q1 | $81.5K | Sell |
28,603
-12,800
| -31% | -$36.5K | 0.01% | 542 |
|
|
2022
Q4 | $301K | Buy |
+41,403
| New | +$301K | 0.05% | 483 |
|
|
2021
Q4 | – | Sell |
-13,523
| Closed | -$381K | – | 922 |
|
|
2021
Q3 | $381K | Sell |
13,523
-4,477
| -25% | -$126K | 0.03% | 533 |
|
|
2021
Q2 | $189K | Sell |
18,000
-2,343
| -12% | -$24.6K | 0.01% | 711 |
|
|
2021
Q1 | $240K | Sell |
20,343
-3,367
| -14% | -$39.7K | 0.02% | 663 |
|
|
2020
Q4 | $278K | Buy |
+23,710
| New | +$278K | 0.02% | 560 |
|